Department of Critical Care Medicine, Taizhou People's Hospital, Taizhou, Jiangsu Province, China.
Clin Cardiol. 2023 Oct;46(10):1173-1184. doi: 10.1002/clc.24063. Epub 2023 Jul 19.
Reduced muscular strength is common in patients with heart failure (HF). The aim of the systematic review and meta-analysis was to evaluate the association between handgrip strength (HGS) and prognosis of patients with HF.
Reduced HGS may be a risk factor of poor prognosis of patients with HF.
Relevant observational studies with longitudinal follow-up were obtained by a comprehensive search of PubMed, Embase, Cochrane Library, and Web of Science databases. A random-effects model was used to pool the results.
Fifteen studies involving 7350 patients with HF were included in the meta-analysis. Pooled results showed that HF patients with lower HGS were associated with a higher risk of mortality during follow-up (risk ratio [RR]: 2.00, 95% confidence interval [CI]: 1.55-2.58, p < .001; I = 0%). Subgroup analysis showed that the association was not significantly affected by characteristics such as study country, design, mean age of the patients, HF status (stable or advanced/acute), HF type (reduced or preserved ejection fraction), follow-up duration, and quality score (p for subgroup difference all > 0.05). Further analysis showed that per 1 kgf decrease of HGS was associated with an 8% increased risk of mortality during follow-up (RR: 1.08, 95% CI: 1.05-1.11, p < .001; I = 12%). Moreover, HF patients with lower HGS were also related to a higher risk of composite outcome of HF rehospitalization or mortality (RR: 1.67, 95% CI: 1.19-2.35, p = .003; I = 53%).
A low HGS may be associated with poor clinical outcomes of patients with HF.
心力衰竭(HF)患者常出现肌肉力量减弱。本系统评价和荟萃分析的目的是评估握力(HGS)与 HF 患者预后之间的关系。
HGS 降低可能是 HF 患者预后不良的危险因素。
通过全面检索 PubMed、Embase、Cochrane 图书馆和 Web of Science 数据库,获得具有纵向随访的观察性研究。使用随机效应模型对结果进行汇总。
纳入的 15 项研究共纳入 7350 例 HF 患者。荟萃分析结果表明,HGS 较低的 HF 患者在随访期间死亡风险较高(风险比 [RR]:2.00,95%置信区间 [CI]:1.55-2.58,p<0.001;I²=0%)。亚组分析表明,这种关联不受研究国家、设计、患者平均年龄、HF 状态(稳定或进展/急性)、HF 类型(射血分数降低或保留)、随访时间和质量评分等特征的显著影响(p 亚组差异均>0.05)。进一步分析表明,HGS 每降低 1kgf,随访期间死亡风险增加 8%(RR:1.08,95%CI:1.05-1.11,p<0.001;I²=12%)。此外,HGS 较低的 HF 患者也与 HF 再住院或死亡的复合结局风险增加相关(RR:1.67,95%CI:1.19-2.35,p=0.003;I²=53%)。
HGS 降低可能与 HF 患者的临床预后不良有关。